AAAAAA

   
Results: 1-8 |
Results: 8
COST-BENEFIT-ANALYSIS OF PROPHYLACTIC GRANULOCYTE-COLONY-STIMULATING FACTOR DURING CHOP ANTINEOPLASTIC THERAPY FOR NON-HODGKINS-LYMPHOMA
Authors: DRANITSARIS G ALTMAYER C QUIRT I
Citation: G. Dranitsaris et al., COST-BENEFIT-ANALYSIS OF PROPHYLACTIC GRANULOCYTE-COLONY-STIMULATING FACTOR DURING CHOP ANTINEOPLASTIC THERAPY FOR NON-HODGKINS-LYMPHOMA, PharmacoEconomics, 11(6), 1997, pp. 566-577
TREATMENT OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY - COMPARISONOF MOPP ABV HYBRID REGIMEN WITH ALTERNATING COURSES OF MOPP AND ABVD - A REPORT FROM THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/
Authors: CONNORS JM KLIMO P ADAMS G BURNS BF COOPER I MEYER RM OREILLY SE PATER J QUIRT I SADURA A SHUSTIK C SKILLINGS J SUTCLIFFE S VERMA S YOSHIDA S ZEE B
Citation: Jm. Connors et al., TREATMENT OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY - COMPARISONOF MOPP ABV HYBRID REGIMEN WITH ALTERNATING COURSES OF MOPP AND ABVD - A REPORT FROM THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/, Journal of clinical oncology, 15(4), 1997, pp. 1638-1645
THE ROLE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN REDUCING RED-BLOOD-CELL TRANSFUSIONS AND MAINTAINING QUALITY-OF-LIFE (QOL) IN PATIENTS WITH LYMPHOMA AND SOLID TUMORS RECEIVING CYTOTOXIC CHEMOTHERAPY - RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL
Authors: QUIRT I COUTURE F PICHETTE R OLWENY C WHITE D KING M SAWKA C HUAN S CLINCH J LAU C
Citation: I. Quirt et al., THE ROLE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN REDUCING RED-BLOOD-CELL TRANSFUSIONS AND MAINTAINING QUALITY-OF-LIFE (QOL) IN PATIENTS WITH LYMPHOMA AND SOLID TUMORS RECEIVING CYTOTOXIC CHEMOTHERAPY - RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL, Blood, 88(10), 1996, pp. 1378-1378
HIV-ASSOCIATED LYMPHOMA OF THE GASTROINTESTINAL-TRACT - THE UNIVERSITY-OF-TORONTO AIDS-LYMPHOMA STUDY-GROUP EXPERIENCE
Authors: IMRIE KR SAWKA CA KUTAS G BRANDWEIN J WARNER E BURKES R QUIRT I MCGEER A SHEPHERD FA
Citation: Kr. Imrie et al., HIV-ASSOCIATED LYMPHOMA OF THE GASTROINTESTINAL-TRACT - THE UNIVERSITY-OF-TORONTO AIDS-LYMPHOMA STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 16(3-4), 1995, pp. 343-349
RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER
Authors: HOLMES CE RUCKDESCHEL JC JOHNSTON M THOMAS PA DESLAURIERS J GROVER FL HILL LD FELD R GINSBERG RJ MOUNTAIN CF DZUIBAN S KIELY M MCKNEALLY MF MOORES DWO RAMNES C WAGNER H BUNN P CHU H DIENHART D HAZUKA M KINZIE J SORENSEN J VANCE V BRAUN T HOPEMAN A KANE M RUSS P WHITMAN GJR FALL SM HANSEN DP HENDERSON RH MONCRIEF CL PAULING F SIMS J TELL D WISELYCARR S ABERNATHY CM CLARK DA MCCROSKEY B MOORE G MOORE F MYERS A WHITE M BROOKS RJ BULL M JOHNSON FB NEIMYR M PAQUETTE FR SACCOMANNO G LAD T HERMANSEN K LIEBNER E MCGUIRE WP FRY W STEMPELFELD B ALEXANDER JC BECK J GARCES RM IMPERATO JP KAHANDEKAR J KNOP R LOCKER G MERKEL DE PANELLA JS ROCHESTER D VICTOR TA JOHNSON C JOOB AW ROBINSON P ROSEN S SHIELDS T DOOLEY S TIO FO HOLLAND C TREASURE RL GOTTFRIED B BEDDINGFIELD G BOWER J CHENG D DALY MB LADD WA LEACH C MURPHY K QUINTON R SMITH VC YOUNG ME BLANTON M BRIGGS R GRISHKIN BA HELSEL R JACKSON D JACKSON ME YOUNG R ZALOZNIK A BLOCK K DAIL DH DREIS D GUYTON SW HAFERMANN M HAMMAR SP JOLLY PC MORGAN E SPRINGMEYER S TAYLOR EW WEIDEN PW KNUDSEN N LIVINGSTON RB RUSCH VW GRAFTON C LERICHE J MURRAY N PAGE R GOODMAN GE AYE RW EVANS KG MILLER RR NELEMS B HIGANO C BERGSAGEL D BROWN TC CURTIS J PAYNE D PRINGLE JF QUIRT I STEWARD L WARR D YEOH L BURKES R COOTER N GOLDBERG M MULLEN B SCHMOCKER B HARRIS F ILVES R SINCLAIR JM SPRATT E BAKER M CHAMBERLAIN DW COOPER JD DESANTIS D EVANS WK PATTERSON GA PEARSON FG RITCHIE AC SHEPHERD FA TAYLOR D TODD TRJ WEBSTER J WINTON TL KIRBY TJ LIPA M FRENCH S SUTTON D WARNER E WATERS PF JONES D HOLMES EC SELCH RA SHIPLACOFF J GANZ P SILVERMAN B HASKELL C SADEGHI A WILLIAMS A WOLLMAN J BLOCH JH CORDER MP HERMES K LUKEMAN JM MURPHY A PIANTADOSI S GOODMAN S RUBINSTEIN LV GAIL MH BOSSENGA M LAKE WH LONG S
Citation: Ce. Holmes et al., RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER, The Annals of thoracic surgery, 60(3), 1995, pp. 615-622
PHASE-II TRIAL TO 10-EDAM IN ADVANCED SOFT-TISSUE SARCOMA - A STUDY OF THE CANADIAN SARCOMA GROUP AND THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP
Authors: KNOWLING M BRAMWELL V EISENHAUER E BOOS G BODURTHA A QUIRT I
Citation: M. Knowling et al., PHASE-II TRIAL TO 10-EDAM IN ADVANCED SOFT-TISSUE SARCOMA - A STUDY OF THE CANADIAN SARCOMA GROUP AND THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP, Annals of oncology, 5(8), 1994, pp. 766-768
A PHASE-II STUDY OF DUP-937 (TELOXANTRONE) IN METASTATIC MALIGNANT-MELANOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP (NCICCTG)
Authors: SHORE T EISENHAUER E QUIRT I BELANGER K LOHMANN R SILVER H WIELGOSZ G
Citation: T. Shore et al., A PHASE-II STUDY OF DUP-937 (TELOXANTRONE) IN METASTATIC MALIGNANT-MELANOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP (NCICCTG), Annals of oncology, 4(8), 1993, pp. 695-696
OUTCOME AND PROGNOSTIC FACTORS IN SOFT-TISSUE SARCOMA IN THE ADULT
Authors: LEVAY J OSULLIVAN B CATTON C BELL R FORNASIER V CUMMINGS B HAO Y WARR D QUIRT I
Citation: J. Levay et al., OUTCOME AND PROGNOSTIC FACTORS IN SOFT-TISSUE SARCOMA IN THE ADULT, International journal of radiation oncology, biology, physics, 27(5), 1993, pp. 1091-1099
Risultati: 1-8 |